These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25481449)

  • 41. Cannabis use disorders in the USA: prevalence, correlates and co-morbidity.
    Stinson FS; Ruan WJ; Pickering R; Grant BF
    Psychol Med; 2006 Oct; 36(10):1447-60. PubMed ID: 16854249
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heavy cannabis users seeking treatment- prevalence of psychiatric disorders.
    Arendt M; Munk-Jørgensen P
    Soc Psychiatry Psychiatr Epidemiol; 2004 Feb; 39(2):97-105. PubMed ID: 15052390
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early reactions to cannabis predict later dependence.
    Fergusson DM; Horwood LJ; Lynskey MT; Madden PA
    Arch Gen Psychiatry; 2003 Oct; 60(10):1033-9. PubMed ID: 14557149
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lifetime associations between cannabis, use, abuse, and dependence and panic attacks in a representative sample.
    Zvolensky MJ; Bernstein A; Sachs-Ericsson N; Schmidt NB; Buckner JD; Bonn-Miller MO
    J Psychiatr Res; 2006 Sep; 40(6):477-86. PubMed ID: 16271364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Hasin DS; Stinson FS; Ogburn E; Grant BF
    Arch Gen Psychiatry; 2007 Jul; 64(7):830-42. PubMed ID: 17606817
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A genetic perspective on the proposed inclusion of cannabis withdrawal in DSM-5.
    Verweij KJ; Agrawal A; Nat NO; Creemers HE; Huizink AC; Martin NG; Lynskey MT
    Psychol Med; 2013 Aug; 43(8):1713-22. PubMed ID: 23194657
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study.
    van der Pol P; Liebregts N; de Graaf R; Korf DJ; van den Brink W; van Laar M
    Drug Alcohol Depend; 2013 Dec; 133(2):352-9. PubMed ID: 23886472
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A survey of patients with substance use disorders at government treatment facilities in the Bahamas.
    Christie K; Clarke N; Frankson M
    West Indian Med J; 2013 Sep; 62(7):610-4. PubMed ID: 24831898
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DSM-IV alcohol dependence and abuse: further evidence of validity in the general population.
    Grant BF; Harford TC; Muthén BO; Yi HY; Hasin DS; Stinson FS
    Drug Alcohol Depend; 2007 Jan; 86(2-3):154-66. PubMed ID: 16814489
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trends in cannabis use disorders among racial/ethnic population groups in the United States.
    Wu LT; Zhu H; Swartz MS
    Drug Alcohol Depend; 2016 Aug; 165():181-90. PubMed ID: 27317045
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psychometric modeling of cannabis initiation and use and the symptoms of cannabis abuse, dependence and withdrawal in a sample of male and female twins.
    Gillespie NA; Kendler KS; Neale MC
    Drug Alcohol Depend; 2011 Nov; 118(2-3):166-72. PubMed ID: 21507586
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cannabis dependence in the San Francisco Family Study: age of onset of use, DSM-IV symptoms, withdrawal, and heritability.
    Ehlers CL; Gizer IR; Vieten C; Gilder DA; Stouffer GM; Lau P; Wilhelmsen KC
    Addict Behav; 2010 Feb; 35(2):102-10. PubMed ID: 19818563
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characteristics of DSM-IV and ICD-10 cannabis dependence among Australian adults: results from the National Survey of Mental Health and Wellbeing.
    Swift W; Hall W; Teesson M
    Drug Alcohol Depend; 2001 Jul; 63(2):147-53. PubMed ID: 11376919
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cannabis dependence in young adults: an Australian population study.
    Coffey C; Carlin JB; Degenhardt L; Lynskey M; Sanci L; Patton GC
    Addiction; 2002 Feb; 97(2):187-94. PubMed ID: 11860390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The structure of cannabis dependence in the community.
    Teesson M; Lynskey M; Manor B; Baillie A
    Drug Alcohol Depend; 2002 Dec; 68(3):255-62. PubMed ID: 12393220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of age at onset of cannabis use on cannabis dependence and driving under the influence in the United States.
    Le Strat Y; Dubertret C; Le Foll B
    Accid Anal Prev; 2015 Mar; 76():1-5. PubMed ID: 25543035
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of cannabis use within a dimensional approach to cannabis use disorders.
    Compton WM; Saha TD; Conway KP; Grant BF
    Drug Alcohol Depend; 2009 Mar; 100(3):221-7. PubMed ID: 19062204
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Properties of the Cannabis Abuse Screening Test (CAST) in the general population.
    Legleye S; Guignard R; Richard JB; Ludwig K; Pabst A; Beck F
    Int J Methods Psychiatr Res; 2015 Jun; 24(2):170-83. PubMed ID: 26077195
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Loose regulation of medical marijuana programs associated with higher rates of adult marijuana use but not cannabis use disorder.
    Williams AR; Santaella-Tenorio J; Mauro CM; Levin FR; Martins SS
    Addiction; 2017 Nov; 112(11):1985-1991. PubMed ID: 28600874
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A dimensional approach to understanding severity estimates and risk correlates of marijuana abuse and dependence in adults.
    Wu LT; Woody GE; Yang C; Pan JJ; Reeve BB; Blazer DG
    Int J Methods Psychiatr Res; 2012 Jun; 21(2):117-33. PubMed ID: 22351489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.